Drug Database
Back to search

Poland· PL-100467540

Framasnoa

A teriflunomid product containing teriflunomidum, registered in Poland by Sigillata Limited. The same ATC class is registered in 4 of our 19 countries.

ATC L04AA31

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFramasnoaATCL04AA31REGISTER NO.PL-100467540PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about teriflunomidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Teriflunomid is registered in 4 of 19 countries.

Countries holding a registration under ATC L04AA31 (teriflunomid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose
Search teriflunomid products by name

Teriflunomid · ATC L04AA31

4 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Teriflunomidum
Manufacturer
Sigillata Limited
Country
Poland (PL)
ATC code
L04AA31
ATC class
Teriflunomid
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 10

  • gtin
    05909991535261
  • gtin
    05909991535254
  • gtin
    05909991535278
  • gtin
    05909991535285
  • gtin
    05909991535292
  • gtin
    05909991535308
  • gtin
    05909991535315
  • gtin
    05909991535322
  • gtin
    05909991535339
  • gtin
    05909991535346

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

668 interactions on record for teriflunomid.

Graded by severity as the source publishes them — 542 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check teriflunomid against other medicinesHow interaction checks work

Teriflunomid · interactions on record

668 records

  • 542 severe
  • 116 moderate
  • 10 minor

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • Chenodeoxycholic acidA05AA01severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AA31

Teriflunomid, as other registers publish it.

All teriflunomid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7b98c253-c5b0-4dff-b2d5-8c8ef5bfabb0
GET /v1/drugs/7b98c253-c5b0-4dff-b2d5-8c8ef5bfabb0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "14 mg",
  "packaging": "05909991535254 ¦ Rpz ¦ 153778\n10 tabl. w blistrze\n05909991535261 ¦ Rpz ¦ 153779\n84 tabl. w blistrze\n05909991535278 ¦ Rpz ¦ 153780\n7 tabl.\n05909991535285 ¦ Rpz ¦ 153781\n14 tabl.\n05909991535292 ¦ Rpz ¦ 153782\n30 tabl. w blistrze\n05909991535308 ¦ Rpz ¦ 153783\n28 tabl. w blistrze\n05909991535315 ¦ Rpz ¦ 153784\n10 tabl. w blistrze perforowanym\n05909991535322 ¦ Rpz ¦ 153785\n84 tabl. w blistrze perforowanym\n05909991535339 ¦ Rpz ¦ 153786\n30 tabl. w blistrze perforowanym\n05909991535346 ¦ Rpz ¦ 153787\n28 tabl. w blistrze perforowanym",
  "substance": "Teriflunomidum 14 mg",
  "common_name": "Teriflunomidum",
  "pl_product_id": "100467540",
  "pozwolenie_nr": "28316",
  "auth_procedure": "DCP",
  "authorisation_validity": "2025-03-10"
}
API referenceMCP serverPlans

See everything about teriflunomid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console